Design of non-covalent inhibitors of human cathepsin L. From the 96-residue proregion to optimized tripeptides


Domain Annotation: ECOD Classification ECOD Database Homepage

ChainsFamily NameDomain Identifier ArchitecturePossible HomologyHomologyTopologyFamilyProvenance Source (Version)
DPico_P1Ae1mhwD01 A: alpha arraysX: RNase A-likeH: RNase A-likeT: RNase A-likeF: Pico_P1AECOD (v295)
B [auth C]Pico_P1Ae1mhwC01 A: alpha arraysX: RNase A-likeH: RNase A-likeT: RNase A-likeF: Pico_P1AECOD (v295)
C [auth B]Flu_M2e1mhwB1 A: alpha arraysX: HTHH: HTHT: Three-helical HTHF: Flu_M2ECOD (v295)
AFlu_M2e1mhwA1 A: alpha arraysX: HTHH: HTHT: Three-helical HTHF: Flu_M2ECOD (v295)

Domain Annotation: CATH CATH Database Homepage

Protein Family Annotation Pfam Database Homepage

ChainsAccessionNameDescriptionCommentsSource
A,
C [auth B]
PF00112Papain family cysteine protease (Peptidase_C1)Papain family cysteine proteaseDomain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

ChainsPolymerMolecular FunctionBiological ProcessCellular Component
E, F, G, H
4-biphenylacetyl-Cys-(D)Arg-Tyr-N-(2-phenylethyl) amide---
B [auth C],
D
Cathepsin L
A,
C [auth B]
Cathepsin L

Pharos: Disease Associations Pharos Homepage Annotation

ChainsDrug Target  Associated Disease
B [auth C],
D
P07711
A,
C [auth B]
P07711

Protein Modification Annotation

Modified Residue(s)
ChainResidue(s)Description
E, F, G, H
BP4
E, F, G, H
DAR
E, F, G, H
PEA
A,
C [auth B]
CSD Parent Component: CYS

AA0262

:  L-cysteine sulfinic acid MOD:00267